Remepy Appoints Eran Harary Chief Medical Officer

Company: Remepy · Event Type: Executive Appointment · New CXO: Eran Harary, M.D. · Context: Joins from Teva ahead of planned global Phase III development of Hybridopa for Parkinson’s disease · Date: September 16, 2026 Summary Remepy appointed Eran Harary, M.D., chief medical officer effective…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Lilly – Ajax JAK2 Deal ($2.3B)
argenx Acquires Forte for $2.2 Billion
LEO Pharma Acquires Dersimelagon for Up to $435 Million
Ultrasound Genetic Medicine Platform Advances Toward Clinic